1. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions
   Shie-Liang Hsieh et al, 2017, Journal of Biomedical Science CrossRef
2. Up-regulation of DcR3 in microbial toxins-stimulated HUVECs involves NF-κB signalling
   Yanqiang Hou et al, 2018, BMC Biochemistry CrossRef
3. The Janus Face of Death Receptor Signaling during Tumor Immunoediting
   Eimear O’ Reilly et al, 2016, Frontiers in Immunology CrossRef
4. The dual role of the CD95 and CD95L signaling pathway in glioblastoma
   Yanrui Zhang et al, 2022, Frontiers in Immunology CrossRef
5. Malignant Fibrous Histiocytoma of the Liver: A Neoplasm of the Undifferentiated High-Grade Pleomorphic Sarcoma Group
   Arthur Zimmermann, 2017, Tumors and Tumor-Like Lesions of the Hepatobiliary Tract CrossRef
6. Malignant Fibrous Histiocytoma of the Liver: A Neoplasm of the Undifferentiated High-Grade Pleomorphic Sarcoma Group
   Arthur Zimmermann, 2016, Tumors and Tumor-Like Lesions of the Hepatobiliary Tract CrossRef
7. Overexpression and Clinicopathological Contribution of DcR3 in Bladder Urothelial Carcinoma Tissues
   Yi-Qiang Jiang et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
8. Decoy Receptor 3 Improves Survival in Experimental Sepsis by Suppressing the Inflammatory Response and Lymphocyte Apoptosis
   DongYu Liang et al, 2015, PLOS ONE CrossRef
9. Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy
   Olivia A. Diaz Arguello et al, 2021, Cancers CrossRef
10. DcR3 gene polymorphisms are associated with sporadic breast infiltrating ductal carcinoma in Northeast Chinese women
    Zhenkun Fu et al, 2016, Oncotarget CrossRef
11. Decoy receptor 3 promotes cell adhesion and enhances endometriosis development
    Hsiao‐Wen Tsai et al, 2018, The Journal of Pathology CrossRef
12. Decoy Receptor 3 Expression Is Associated With Wild-Type EGFR Status, Poor Differentiation of Tumor, and Unfavorable Patient Outcome
    Wei-Chin Chang et al, 2019, American Journal of Clinical Pathology CrossRef